from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2311/-

LFCtreatmentdescriptionclass of inhibitor

0.724

Amikacinug/mL Amikacintranslation

0.048

Cap5-10ug/mL Capreomycintranslation

0.434

Rox10-50 ug/mL Roxithromycintranslation

-0.993

SM2-5 ug/mL Streptomycintranslation

0.561

Tet5-10 ug/mL Tetracyclinetranslation

0.932

Rif0.2-5ug/mL Rifampicintranscription

0.359

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.236

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.080

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.039

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.757

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.109

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.128

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.104

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.100

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.413

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.373

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.038

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.299

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.013

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.012

KCN5-20 ug/mL Potassium cyaniderespiration

-0.409

NaN30.2-2 mM Sodium aziderespiration

-0.514

Nigericin50 uM Nigericinrespiration

0.808

TRC10-150 ug/mL Triclosanrespiration

0.492

TRZ10-25 ug/mL Thioridazinerespiration

-0.785

Valinomycin0.5-10 uM Valinomycinrespiration

-1.874

ZnSO42 mM ZnSO4respiration

-0.130

menadione6-10 ug/mL Menadionerespiration

0.363

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.357

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.073

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.909

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.513

NRP_1Non-replicating persistence stage 1dosRassociated

-0.594

Amp0.2mg/mL AmpicillincellWall

0.285

Cephalexin20-100 ug/mL CephalexincellWall

0.025

Cerulenin0.32-5 ug/mL CerulenincellWall

0.316

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.156

EMB10-20 ug/mL EthambutolcellWall

-0.560

Eta12-40 ug/mL EthionamidecellWall

-0.983

INH0.2-0.4 ug/mL IsoniazidcellWall

0.038

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.491

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.022

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.247

BZA0.12 mg/mL BenzamidearomaticAmides

-0.041

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.279

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.835

H2O24 mM hydrogen peroxideDNAdamaging

0.166

Levo10 ug/mL LevofloxacinDNAdamaging

-0.610

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.450

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.853

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.589

UVUV-irradiationDNAdamaging

1.336

ARP41-4 ug/mL Antitubercular compound ARP4?

0.280

Antimycin12.5-50 ug/mL Antimycin A?

-0.246

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.440

PA_110-50 ug/mL Antitubercular compound PA-1?

0.423

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.993

PA8240.2-2 ug/mL PA-824?

0.328

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.499

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.133

Verapamil50 uM Verapamil?

-0.196

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.120

methoxatin10-20 ug/mL Methoxatin?